Health Professional Event – US Neurologist to Give Talk on New Therapies for Migraine
Date(s) - 07/10/2017
10:15 am - 12:45 pm
Maldron Hotel, Dublin Airport
The Migraine Association of Ireland will be holding a free Health Professional Event in the Maldron Hotel, Dublin Airport Saturday the 7th of October from 10.00 am – 12.45 pm.
The event will be led by Dr. Stewart J. Tepper, M.D., Professor of Neurology at the Geisel School of Medicine at Dartmouth (Dartmouth Medical School) in Hanover, New Hampshire. Dr. Stewart Tepper is a leading expert in the area of anti-CGRP drugs. He was a key advisor to all three pharmaceutical companies involved in developing these drugs during patient clinical trials in the US.
Dr. Tepper will present a comprehensive overview of CGRP inhibitors for the prevention and acute treatment of migraine. This presentation will be a first for the Irish healthcare industry.
CGRP (Calcitonin Gene Related Peptide) is a neuropeptide which is released into the blood stream during a migraine attack and is believed to have a central role in the underlying mechanisms of a migraine attack. CGRP drugs block the activity of these peptides, which spike during a migraine attack. Recent results from final Phase 3 clinical trials targeting CGRPs are producing positive results, with these drugs expected to reach the US market in 2018.
During this seminar, Dr. Tepper will also provide a comprehensive overview of the current medications available for the treatment of migraine and headache. He will discuss the use of neuromodulation in the treatment of migraine. Neuromodulation is a relatively new treatment for migraine patients and involves direct stimulation of the nervous system with electrical signals.
CPD points have been awarded from the RCPI and NMBI.
If you wish to attend, please go to our Eventbrite page for a FREE Ticket or you can call us on 01 894 1280 or email firstname.lastname@example.org
Please be aware that this event is for HEALTH PROFESSIONALS ONLY